Eversense CGM for Diabetes
(PAS Trial)

Recruiting in Palo Alto (17 mi)

+16 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Senseonics, Inc.

No Placebo Group

Trial Summary

What is the purpose of this trial?

A Post Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System over repeat insertion and removal cycles and to demonstrate the long-term safety of the Eversense® CGM System

Eligibility Criteria

This trial is for adults over 18 years old with any type of diabetes. It's not suitable for those who are critically ill, hospitalized, pregnant or nursing women, or people using other CGM systems or certain insulin pumps.

Inclusion Criteria

I am over 18 years old.

I have diabetes.

Exclusion Criteria

I need mannitol through an IV or as an irrigation solution.

I am not pregnant, planning to become pregnant, or nursing.

You are using a hybrid closed loop system or a closed loop system for managing your condition.

See 3 more

Treatment Details

Interventions

Eversense® CGM system (Continuous Glucose Monitoring)

Trial OverviewThe study tests the long-term safety and effectiveness of the Eversense® Continuous Glucose Monitoring System through multiple cycles of insertion and removal in managing diabetes.

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Continuous Glucose Monitoring DeviceExperimental Treatment1 Intervention